Presentation is loading. Please wait.

Presentation is loading. Please wait.

Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy  Takayuki Gyoten, MD, Toshio Doi, MD, Saori.

Similar presentations


Presentation on theme: "Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy  Takayuki Gyoten, MD, Toshio Doi, MD, Saori."— Presentation transcript:

1 Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy  Takayuki Gyoten, MD, Toshio Doi, MD, Saori Nagura, MD, Akio Yamashita, MD, Kazuaki Fukahara, MD, Keiju Kotoh, MD, Naoki Yoshimura, MD  The Annals of Thoracic Surgery  Volume 99, Issue 3, Pages (March 2015) DOI: /j.athoracsur Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Preoperative imaging findings. (A) Enhanced computed tomography at admission reveals a heterogeneous mass (60 × 75 mm) in the right atrium (arrow). (B) Multiple mass lesions in the bilateral lung fields. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Tumor pathologic findings. (A) The tumor was resected en bloc with the atrial free wall. Bar = 10.0 mm. (B) Microscopy reveals diffuse proliferation of atypical lymphocytes with round atypical nuclei. (Hematoxylin and eosin, ×400). Bar = 50.0 μm. (C) Immunohistochemistry showed that the tumor cells were strongly positive for CD20 (×400). Bar = 50.0 μm. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions


Download ppt "Primary Cardiac Malignant Lymphoma: Survival for 13 Years After Surgical Resection and Adjuvant Chemotherapy  Takayuki Gyoten, MD, Toshio Doi, MD, Saori."

Similar presentations


Ads by Google